The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer
出版年份 2018 全文链接
标题
The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer
作者
关键词
Cancer treatment, Non-small cell lung cancer, Toxicity, Progressive diseases, Inflammation, T cells, Histology, Cancer immunotherapy
出版物
PLoS One
Volume 13, Issue 2, Pages e0193018
出版商
Public Library of Science (PLoS)
发表日期
2018-02-16
DOI
10.1371/journal.pone.0193018
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade
- (2017) Esra A. Akbay et al. Journal of Thoracic Oncology
- Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
- (2017) Stefan Diem et al. LUNG CANCER
- Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
- (2017) Stephen J. Bagley et al. LUNG CANCER
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy
- (2016) Rossana Berardi et al. Oncotarget
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation
- (2015) Selma Rivas-Fuentes et al. Journal of Cancer
- Prognostic Significance of Basic Laboratory Methods in Non-Small-Cell-Lung Cancer
- (2014) Vildan Kaya et al. Asian Pacific Journal of Cancer Prevention
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients
- (2013) Cirino Botta et al. CANCER BIOLOGY & THERAPY
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
- (2013) Graeme J.K. Guthrie et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
- (2012) Yanwen Yao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer
- (2012) S. Cedrés et al. Clinical & Translational Oncology
- Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy
- (2012) Youngjoo Lee et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
- (2012) Takashi Motomura et al. JOURNAL OF HEPATOLOGY
- A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer
- (2011) S. Reppert et al. Nature Communications
- Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer
- (2010) Yan Zhang et al. Cellular & Molecular Immunology
- Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03
- (2009) Satoshi Teramukai et al. EUROPEAN JOURNAL OF CANCER
- An overview of IL-17 function and signaling
- (2008) Sarah L. Gaffen CYTOKINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started